Amwise Diagnostic

Türkiye
Maden, Bayburt Province, Turkey

Company profile

Amwise Diagnostic company profile

Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.

Business identity

Contact email
[email protected]
Phone number
+0800-271-271
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Country code
TR
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$10M
Last funding
Series B / $10M / 2020-02-26
Last equity funding
Series B / $10M
Investors
4
Lead investors
1
Founders
1
Articles
2

Founders and investors

Founders

Xianlin Huang

Lead investors

Simcere Pharma

Investors

Alibaba Entrepreneurs FundLippo GroupSimcere PharmaWI Harper Group